中文

Journal Publications

[1]Xingxing Peng#, Qi-Wen Chen#, Jing Chang, Yongbo Liu, Yanfei Liu*, Zhenbao Liu*, Self-assembled ferric–shikonin–quercetin (FSQ) nanoparticles co-delivering R848 enable lactate reduction, ICD induction, and immune modulation in vitro, Colloids and Surfaces B: Biointerfaces, 2026, 116229.
[2]Qi-Wen Chen, Jian Wu, Qianqian Chen, Yunqi Man, Yifu Tan, Yanfei Liu*, Zhenbao Liu*, Dual-Energy Blockade via Fe3+/EGCG/2‐DG/Sesamin (FEDS): A Homologous Biomimetic Self-Assembled Nanoplatform for Tumor Starvation Therapy, Chinese Chemical Letters, 2026, 113491.
[3]Yunqi Man#, Yanfei Liu#, Yongbo Liu, Jian Wu, Yifu Tan, Zhongyu Cheng, Luke P. Lee, Qi-Wen Chen*, Zhenbao Liu*, Inhalable Mucus-Penetrating and Senescence-Targeted Nanoliposomes Reverse Senescence to Overcome Chemoresistance for Enhanced Lung Cancer Therapy, Biomaterials, 2026, 124658.
[4]Junjie Wu, Lishang Xu, Qi-Wen Chen, Lu Yu*, Zhenbao Liu*, Anjie Xia*, Bacterial metabolic–immune reprogramming in cancer: from living vectors to engineered biofactories, Journal of Controlled Release, 2026, 399，115394.
[5]Zexiang Lv#, Yanfei Liu#, Yongbo Liu, Yifu Tan, Yunqi Man, Shuqing Du, Zhirou Zhang, Luke P. Lee, Qi-Wen Chen*, Zhenbao Liu*, Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics, ACS Biomaterials Science & Engineering, 2026, 6c00849.
[6]Jungang Ren#, Qian Wu#, Luke P. Lee, Zhenbao Liu*, Cellular and In Vivo Fate of DNA Nanostructures, ACS Applied Materials & Interfaces, 2026, 6c09876.
[7]Jiajun Liu#, Yongbo Liu#, Yanfei Liu#, Yang Chen, Xiang Xu, Yanna Chen, Jianfei Lu, Nian Liao, Zhiqun Guo, Yuxuan Zhai, Li Ma*, Zhenbao Liu*, Plant-Derived Nanovesicles: From Biogenesis and Lipid Fingerprints to Gut–Organ Axis and Smart Biomaterial Platforms, ACS Applied Bio Materials, 2026, 9 (17): 7893–7907.
[8]Shuqing Du#, Yanfei Liu#, Yongbo Liu#, Yifu Tan, Yunqi Man, Zhirou Zhang, Zexiang Lv, Luke P. Lee, Qi-Wen Chen*, Zhenbao Liu*，Multidimensional interactions of living materials with biological entities，Biomaterials, 2026, 124565.
[9]Zhenbao Liu*, DNA nanotechnology in therapeutic modulation and bio-inspired systems for precision medicine, 2026, Biomedical Engineering Communications, 2027, 6(2): 7.
[10]Chu Wu#, Hao Cui#, Xinyu Yan, Yue Tang, Ruotong Wu, Ruihan Qiang, Yao Wu, Xingqi Pan, Qunxiang Lin, Zhenbao Liu*, Meilin Shi*, Ultrasound-Mediated Thrombolysis: From Mechanistic Insights to Advanced Nanoplatforms and Clinical Translation, 2026, Advanced Healthcare Materials. 15: e71296.
[11]Z. Ren, C. Peng, Y. Liu, B. Lin, Y. Man, Y. Tan, Zhenbao Liu*, Q. Chen*, In Situ Electroactive Bacteria-Activated Nanozyme for Amplifying Chemodynamic Therapy of Solid Tumors, Nano Letters. 2026, 26, 6857-6867
[12]Rami Abduljabbar, Al-Motassem Yousef*, Duaa Eid Tamimi, Shayma Z. Abdullah, Zhenbao Liu, Association of ABCB1 Genetic Variants with Epilepsy Susceptibility in Jordanian Cohort, Neurology International, 2026, 18, 75.
[13]Zhenbao Liu*, Mingxu You, DNA-based nanostructures: advancing drug delivery and disease therapy, Advanced Drug Delivery Reviews, 234, 2026, 115878.
[14]Xinyi Guo, Mengmeng Wang, Danyang Qu, Hao Cui, Jiajing Gong, Qinglin Shen, Yang Han, Xingqi Pan, Zhenbao Liu*, and Meilin Shi*, Nanoflower Structured HA-MnO2-TCPP Nanoplatform for MRI-Guided Synergistic Sonodynamic and Chemodynamic Tumor Therapy, ACS Applied Materials & Interfaces, 2026, 18 (9): 13599–13610
[15]Qian Liu#, Binliang Liu#, Zhenbao Liu, Lidan Gong, Min Li*, Xiangjian Luo*, A viral–host redox axis: EBNA1–FOSL2–ALDH3A1 defines a targetable vulnerability in EBV-positive carcinomas, Redox Biology, 2026, 104025.
[16]Lishang Xu#, Kan Shao#, Yanfei Liu#, Yongbo Liu, Yifu Tan, Yunqi Man, Zhirou Zhang, Zhongyu Cheng, Qian Wang, Zhihang Ren, Jian Wu, Qi-Wen Chen*, Zhenbao Liu*, Antigen-Enriched Tumor-Dendritic Cell Fusion Membrane-Coated Metal-Phenolic Nanovaccine Enables Dual T-Cell Activation for Robust Cancer Immunotherapy, Advanced Healthcare Materials, 2026, e05255.
[17]Yujie Yan#, Pengtao Wang#, Xi Tang#, Yuhang Wang, Mengting Xiao, Zhenbao Liu, Xiaolin Tu*, Xian Li*, Engineered Dll4-overexpressing osteocyte-derived exosomes enhanced bone regeneration by regulating osteogenesis and angiogenesis, Theranostics, 2026; 16(6): 2780-2797.
[18]Zhirou Zhang#, Yanfei Liu#, Qiwen Chen, Yongbo Liu, Yifu Tan, Yungi Man, Zhongyu Cheng, Kan shao, Qian Wang, Shuging Du, Zexiang Lv, Zhenbao Liu, Functional Nucleic Acids for Cell-Cell Interactions, Small (2025): e12348.
[19]Hao Cui#, Chen Ni#, Mengmeng Wang#, Jie Huang, Danyang Qu, Jinfeng Yang, Xingqi Pan, Zhenbao Liu*, Meilin Shi*. Smart Tumor Oxygen Supply Strategy Enables Dual‐Modality Fluorescence/MR Imaging and Synergistic Therapy of Triple‐Negative Breast Cancer, Adv. Healthcare Mater. (2025): e03886.
[20]Rami Abduljabbar#, Yanfei Liu#, Ali Mussa, Amir Mohammed Abker Abdu, Yunqi Man, Qiwen Chen, Zhenbao Liu*, Targeting Cellular Senescence for Cancer Therapy, International Journal of Pharmaceutics, 2025, 126297

total74 1/4

firstpreviousnext last Page

Zhenbao Liu

Zip Code:
Postal Address:
Email:

Central South University All rights reserved 湘ICP备05005659号-1

Click:

The Last Update Time:..